EP0961614A4 - Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung - Google Patents

Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung

Info

Publication number
EP0961614A4
EP0961614A4 EP97952599A EP97952599A EP0961614A4 EP 0961614 A4 EP0961614 A4 EP 0961614A4 EP 97952599 A EP97952599 A EP 97952599A EP 97952599 A EP97952599 A EP 97952599A EP 0961614 A4 EP0961614 A4 EP 0961614A4
Authority
EP
European Patent Office
Prior art keywords
tricarboxylic acid
containing oxyalkyl
oxyalkyl esters
esters
tricarboxylic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP97952599A
Other languages
English (en)
French (fr)
Other versions
EP0961614A1 (de
Inventor
Abraham Nudelman
Ada Rephaeli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bar Ilan University
Mor Research Applications Ltd
Original Assignee
Bar Ilan University
Mor Research Applications Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/781,905 external-priority patent/US6130248A/en
Application filed by Bar Ilan University, Mor Research Applications Ltd filed Critical Bar Ilan University
Publication of EP0961614A1 publication Critical patent/EP0961614A1/de
Publication of EP0961614A4 publication Critical patent/EP0961614A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/34—Esters of acyclic saturated polycarboxylic acids having an esterified carboxyl group bound to an acyclic carbon atom
    • C07C69/42—Glutaric acid esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP97952599A 1996-12-30 1997-12-30 Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung Withdrawn EP0961614A4 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/781,905 US6130248A (en) 1996-12-30 1996-12-30 Tricarboxylic acid-containing oxyalkyl esters and uses thereof
US781905 1996-12-30
US81436597A 1997-03-11 1997-03-11
US814365 1997-03-11
PCT/US1997/023725 WO1998029114A1 (en) 1996-12-30 1997-12-30 Tricarboxylic acid-containing oxyalkyl esters and uses thereof

Publications (2)

Publication Number Publication Date
EP0961614A1 EP0961614A1 (de) 1999-12-08
EP0961614A4 true EP0961614A4 (de) 2002-07-24

Family

ID=27119918

Family Applications (1)

Application Number Title Priority Date Filing Date
EP97952599A Withdrawn EP0961614A4 (de) 1996-12-30 1997-12-30 Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung

Country Status (3)

Country Link
EP (1) EP0961614A4 (de)
AU (1) AU5617398A (de)
WO (1) WO1998029114A1 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6228362B1 (en) 1992-08-21 2001-05-08 Immunomedics, Inc. Boron neutron capture therapy using pre-targeting methods
AU7993500A (en) * 1999-11-15 2001-05-30 New Millennium Pharmaceutical Research, Inc. Intranasal administration of raloxifene and tamoxifen
EP1170008A1 (de) * 2000-07-07 2002-01-09 Chemotherapeutisches Forschungsinstitut Georg-Speyer-Haus Valproinsäure und dessen Derivate als Inhibitoren der Histone deacetylase
AUPR059400A0 (en) * 2000-10-06 2000-11-02 Bar-Ilan University Formaldehyde-releasing prodrugs
US6562995B1 (en) 2000-12-21 2003-05-13 Beacon Laboratories, Inc. Delta dicarbonyl compounds and methods for using the same
EA200800321A1 (ru) 2005-07-14 2008-06-30 Такеда Сан Диего, Инк. Ингибиторы гистондеацетилазы
EP2650279A3 (de) 2008-08-19 2014-02-12 XenoPort, Inc. Methylwasserstoff-prodrugs, pharmazeutische zusammensetzungen daraus und anwendungsverfahren
WO2014031844A1 (en) 2012-08-22 2014-02-27 Xenoport, Inc. Methods of administering monomethyl fumarate and prodrugs thereof having reduced side effects
AU2013305684B2 (en) 2012-08-22 2016-11-24 Xenoport, Inc. Oral dosage forms of methyl hydrogen fumarate and prodrugs thereof
US8669281B1 (en) 2013-03-14 2014-03-11 Alkermes Pharma Ireland Limited Prodrugs of fumarates and their use in treating various diseases
RS57497B1 (sr) 2013-03-14 2018-10-31 Alkermes Pharma Ireland Ltd Prolekovi fumarata i njihova upotreba u lečenju raznih bolesti
US10179118B2 (en) 2013-03-24 2019-01-15 Arbor Pharmaceuticals, Llc Pharmaceutical compositions of dimethyl fumarate
WO2014197860A1 (en) 2013-06-07 2014-12-11 Xenoport, Inc. Method of making monomethyl fumarate
US9421182B2 (en) 2013-06-21 2016-08-23 Xenoport, Inc. Cocrystals of dimethyl fumarate
TW201516020A (zh) 2013-09-06 2015-05-01 Xenoport Inc （ｎ，ｎ－二乙基胺甲醯基）甲基（２ｅ）丁－２－烯－１，４－二酸甲酯之晶形、合成方法及用途
EP3110793B1 (de) 2014-02-24 2019-08-21 Alkermes Pharma Ireland Limited Sulfonamid und sulfinamid-prodrugs von fumaraten und deren verwendung zur behandlung verschiedener erkrankungen
US9999672B2 (en) 2014-03-24 2018-06-19 Xenoport, Inc. Pharmaceutical compositions of fumaric acid esters
WO2017060422A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of mitochondrial disorders
WO2017060418A1 (en) * 2015-10-07 2017-04-13 Neurovive Pharmaceutical Ab Protected carboxylic acid-based metabolites for the treatment of mitochondria-related diseases
HUE057970T2 (hu) 2018-03-08 2022-06-28 Incyte Corp Aminopirazindiol-vegyületek mint PI3K-Y inhibitorok
US11046658B2 (en) 2018-07-02 2021-06-29 Incyte Corporation Aminopyrazine derivatives as PI3K-γ inhibitors

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) * 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0276942A1 (de) * 1987-01-27 1988-08-03 Pfizer Inc. 6-Beta(substituierte)-(S)-hydroxymethylpenicillansäure und deren Derivate
JPH06192273A (ja) * 1992-10-26 1994-07-12 Lederle Japan Ltd カルバペネム−３−カルボン酸エステル誘導体

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4462934A (en) * 1983-03-31 1984-07-31 Pfizer Inc. Bis-esters of dicarboxylic acids with amoxicillin and certain hydroxymethylpenicillanate 1,1-dioxides
EP0276942A1 (de) * 1987-01-27 1988-08-03 Pfizer Inc. 6-Beta(substituierte)-(S)-hydroxymethylpenicillansäure und deren Derivate
JPH06192273A (ja) * 1992-10-26 1994-07-12 Lederle Japan Ltd カルバペネム−３−カルボン酸エステル誘導体

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Derwent World Patents Index; *
PATENT ABSTRACTS OF JAPAN vol. 018, no. 542 (C - 1261) 17 October 1994 (1994-10-17) *
See also references of WO9829114A1 *

Also Published As

Publication number Publication date
WO1998029114A1 (en) 1998-07-09
EP0961614A1 (de) 1999-12-08
AU5617398A (en) 1998-07-31

Similar Documents

Publication Publication Date Title
EP0961614A4 (de) Oxyalkylester die tricarboxylsaeuren enthalten und deren verwendung
PL320203A1 (en) 2-cyanoacrylic esters
GB9615089D0 (en) Esters and compositions comprising them
AU4997397A (en) Card-recognition and gaming-control device
EP0759752A4 (de) Behandlung von atherosklerose und anderen kardiovaskulären und entzündlichen erkrankungen
EP0897570A4 (de) Feuchtigkeitsdetektionsvorrichtung zum beispiel für windeln und windeln damit
EP1021185A4 (de) Dihydropyrimidine und ihre verwendungen.
EP0897570A3 (de) Feuchtigkeitsdetektionsvorrichtung zum beispiel für windeln und windeln damit
HK1002864A1 (en) Water-dissoluble narobomycin ester
IL122428A0 (en) Minizymes and minribozymes and uses thereof
IL128675A0 (en) Heterocyclic esters and amides
IL126758A0 (en) Alkyl-4-silyl-phenols and esters thereof as antiatherosclerotic agents
SI0635478T1 (en) Acrylates and methacrylates based on cyclohexyldiphenols
AU3227197A (en) Lactoferrin variants and uses thereof
GB2317397B (en) Rolling member and device
AU5836498A (en) N-acyl-hydroxyamino acid esters and their use
HUP9900911A3 (en) Esters and amides as pla2 inhibitors
IL114305A0 (en) 2,4,6-triiodo-5-substituted-amino-isophthalate esters and their use
PL331523A1 (en) Azolotrizines and azolopyrimidines
HUP9801890A3 (en) Pyridyncarboxylic amides and esters and preparation thereof
IL116134A0 (en) Iminooxybenzylcrotonate esters their preparation and their use
GB9615086D0 (en) Carboxylic acid esters,and compositions comprising them
HUP9900068A3 (en) Fuse-switch and/or fuse-disconnector
PL324340A1 (en) Novel quinoxalinophosphonic and quinoxalinoalkanophosphonic acids
GB9618423D0 (en) Structure and device

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19990730

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 19990730;LT PAYMENT 19990730;LV PAYMENT 19990730;MK PAYMENT 19990730;RO PAYMENT 19990730;SI PAYMENT 19990730

A4 Supplementary search report drawn up and despatched

Effective date: 20020610

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20020903